Articles citing this paper
Cannabis Phytochemicals: A Review of Phytocannabinoid Chemistry and Bioactivity as Neuroprotective Agents
Dylan T. Marsh A and Scott D. Smid 
A B
+ Author Affiliations
- Author Affiliations
A Discipline of Pharmacology, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA 5005, Australia.
B Corresponding author. Email: scott.smid@adelaide.edu.au
Mr Dylan Marsh is undertaking his Ph.D. in the discipline of pharmacology in the Faculty of Health and Medical Sciences at the University of Adelaide. His work aims to explore and characterize the potential role of natural products as neuroprotective and anti-inflammatory agents, with a particular focus on the use of phytocannabinoids.
|
Dr Scott Smid is a pharmacologist specializing in drug discovery and development research, both in the pharmaceutical industry and academia. He maintains a strong research interest in experimental therapeutics applied towards novel treatments for gastrointestinal and neurodegenerative diseases. This includes investigating the biological actions of phytocannabinoids, synthetic cannabinoids, and endocannabinoids in areas as diverse as gut function, inflammation, and neurodegeneration.
|
Australian Journal of Chemistry 74(6) 388-404 https://doi.org/10.1071/CH20183
Submitted: 4 June 2020 Accepted: 13 August 2020 Published: 18 September 2020
A phlorotannin isolated from Ecklonia radiata, Dibenzodioxin-fucodiphloroethol, inhibits neurotoxicity and aggregation of β-amyloid
Shrestha Srijan,
Johnston Martin R.,
Zhang Wei, Smid Scott D.
Phytomedicine Plus. 2021 1(4). p.100125
Characterizing cannabis-prevalent terpenes for neuroprotection reveal a role for α and β-pinenes in mitigating amyloid β-evoked neurotoxicity and aggregation in vitro
Laws John Staton, Smid Scott D.
NeuroToxicology. 2024 100 p.16
Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases
Corsato Alvarenga Isabella,
Panickar Kiran S.,
Hess Hannah, McGrath Stephanie
Annual Review of Animal Biosciences. 2023 11(1). p.227
Medicinal Usage of Cannabis and Cannabinoids (2023)
Laws John Staton,
Shrestha Srijan, Smid Scott D.
Cannabis and Cannabinoids
Duggan Peter J., Kassiou Michael
Australian Journal of Chemistry. 2021 74(6). p.367
Selected phytocannabinoids inhibit SN-38- and cytokine-evoked increases in epithelial permeability and improve intestinal barrier function in vitro
Marsh Dylan T., Smid Scott D.
Toxicology in Vitro. 2024 99 p.105888
A Comprehensive Review on Cannabis sativa Ethnobotany, Phytochemistry, Molecular Docking and Biological Activities
Hourfane Sohaib,
Mechqoq Hicham,
Bekkali Abdellah Yassine,
Rocha João Miguel, El Aouad Noureddine
Plants. 2023 12(6). p.1245
Intelligent framework for cannabis classification using visualization of gas chromatography/mass spectrometry data and transfer learning
Huang Ting-Yu, Yu Jorn Chi Chung
Frontiers in Analytical Science. 2023 3
Evaluating Cannabis sativa L.’s neuroprotection potential: From bench to bedside
Laws John Staton, Smid Scott D.
Phytomedicine. 2022 107 p.154485
Phytocannabinoids in neuromodulation: From omics to epigenetics
Banerjee Subhadip,
Saha Debolina,
Sharma Rohit,
Jaidee Wuttichai,
Puttarak Panupong,
Chaiyakunapruk Nathorn, Chaoroensup Rawiwan
Journal of Ethnopharmacology. 2024 330 p.118201
Role of Cannabinoids in Various Diseases: A Review
Kaur Simran,
Sharma Nikita, Roy Arpita
Current Pharmaceutical Biotechnology. 2022 23(11). p.1346
The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β‐evoked neurotoxicity and changes in cell morphology in PC12 cells
Marsh Dylan T.,
Sugiyama Ayato,
Imai Yuta,
Kato Ryuji, Smid Scott D.
Basic & Clinical Pharmacology & Toxicology. 2024 134(3). p.293
